NasdaqCM - Delayed Quote USD
Celldex Therapeutics, Inc. (CLDX)
20.66
-0.05
(-0.24%)
At close: May 2 at 4:00:01 PM EDT
20.66
0.00
(0.00%)
After hours: May 2 at 4:05:10 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-157,778
-157,778
-107,291
-103,732
-60,909
Investing Cash Flow
-290,129
-290,129
-105,782
89,942
-216,156
Financing Cash Flow
441,449
441,449
218,458
4,076
272,372
End Cash Position
28,356
28,356
34,814
29,429
39,143
Capital Expenditure
-1,919
-1,919
-1,818
-1,828
-1,249
Issuance of Capital Stock
432,298
432,298
216,222
--
269,893
Free Cash Flow
-159,697
-159,697
-109,109
-105,560
-62,158
12/31/2021 - 5/15/1986
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MLTX MoonLake Immunotherapeutics
42.32
+2.12%
AKRO Akero Therapeutics, Inc.
44.87
-0.97%
CYTK Cytokinetics, Incorporated
37.35
-12.98%
MRUS Merus N.V.
44.19
-2.77%
SRRK Scholar Rock Holding Corporation
32.91
+0.46%
XENE Xenon Pharmaceuticals Inc.
38.28
+0.50%
JSPR Jasper Therapeutics, Inc.
5.41
+0.56%
EWTX Edgewise Therapeutics, Inc.
16.91
+1.38%
ATXS Astria Therapeutics, Inc.
5.36
+3.88%
ACLX Arcellx, Inc.
65.55
+0.03%